HOME >> MEDICINE >> NEWS
Two anticoagulant therapies for treating acute coronary syndromes show similar outcomes at one year

High-risk patients with acute coronary syndromes (ACS) treated with an early revascularization strategy and enoxaparin or unfractionated heparin at the time of hospitalization for ACS had similar outcomes at one year, including remaining at substantial risk for adverse cardiovascular events, according to a study in the November 23/30 issue of JAMA.

Patients with nonST-segment elevation (NSTE - a certain pattern on an electrocardiogram) acute coronary syndromes (ACS) comprise a spectrum of risk for adverse cardiac events, according to background information in the article. In the Superior Yield of the New Strategy of Enoxaparin, Revascularization, and Glycoprotein IIb/IIIa Inhibitors (SYNERGY) trial, patients at high risk for recurrent ischemic cardiac events were randomly assigned to receive the anticoagulants low-molecular-weight heparin (enoxaparin) or unfractionated heparin. The primary results at 30 days showed that enoxaparin was at least as effective as unfractionated heparin in reducing death or nonfatal myocardial infarction (MI heart attack). The current study examines the results at six months and one year. "We believe this to be valuable, given the high-risk clinical characteristics of the patient population in SYNERGY and the need to understand the long-term outcomes in patients managed with an early aggressive invasive treatment strategy," the researchers write.

Kenneth W. Mahaffey, M.D., of Duke Clinical Research Institute, Durham, N.C., and colleagues analyzed follow-up data at 6 months and one year from the SYNERGY trial, which included 9,978 patients who were randomized from August 2001 through December 2003 in 487 hospitals in 12 countries. At six months, 541 patients (5.4 percent) had died, and 739 (7.4 percent) had died at one year. The researchers found that death or nonfatal MI at six months occurred in 872 patients receiving enoxaparin (17.6 percent) vs. 884 receiving unfractionated (not separated) heparin (17.8 percent). Reh
'"/>

Contact: Richard Merritt
919-660-1309
JAMA and Archives Journals
22-Nov-2005


Page: 1 2

Related medicine news :

1. Patient self-management of oral anticoagulant therapy cost-effective
2. Future therapies for stroke may block cell death
3. Antifolate therapies found effective against certain type of malaria
4. Combined molecular-targeted and hormonal therapies offer promise in treating ovarian cancer
5. A sweet step toward new cancer therapies
6. Psychological therapies for common anxiety disorder not readily available in primary care settings
7. About 5 percent of adults with insomnia use alternative therapies
8. Combined therapies may boost immune response and long-term protection against brain tumors
9. New hope in cancer vaccines emerges as novel therapies are developed and tested
10. NICE gives backing for the use of advanced biological therapies to treat severe psoriasis
11. Complementary and alternative therapies show little benefit in treating menopause symptoms

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/23/2020)... ... ... SignatureCare Emergency Center is set to expand to North Dallas with the opening ... heart of Lewisville, on 1596 W. Main St., Lewisville, TX 75067, the new location ... , It will serve residents and businesses around Lewisville, TX, including Double Oak, Copper ...
(Date:1/23/2020)... Okla (PRWEB) , ... January 23, 2020 , ... ... partnered with RespirCare, LLC, a first-of-its-kind, full-service pulmonology clinic based in Tulsa, to ... Under the agreement, MCNDOH patients will also have access to HGE Health’s digital ...
(Date:1/23/2020)... ... 2020 , ... Let’s face it; the holidays were a stressful time, a ... and secrets were revisited. It’s easy to understand why many folks prefer to duck ... families, the holidays posed additional stress for which there is no “cookie-cutter” solution. , ...
(Date:1/23/2020)... ... January 23, 2020 , ... Merger and acquisition activity in the Physician Medical ... according to data from HealthCareMandA.com. The total is the lowest reported in the previous ... deals were announced. , One deal disclosed a price in the fourth quarter of ...
(Date:1/23/2020)... ... January 23, 2020 , ... MemoryCare.com , a ... the Best Memory Care Facilities in Pensacola, Florida. The guide identifies 7 memory ... , According to the Alzheimer’s Association , 5.6 million people age 65 ...
Breaking Medicine News(10 mins):
(Date:1/23/2020)... ... January 23, 2020 , ... “It’s complicated.” The phrase ... architecture providing function to a person’s hand, wrist, arm and shoulder. “Which is ... surgeon -- when anything goes wrong up or down this superhighway of interconnected ...
(Date:1/22/2020)... SHIRLEY, N.Y. (PRWEB) , ... January 22, 2020 ... ... of its new Biodex Advantage BX software to U.S. customers. A total redesign ... System 4 Dynamometer with more streamlined functionality and intuitive navigation, while maintaining the ...
(Date:1/22/2020)... FRANKLIN, Tenn. (PRWEB) , ... January 22, 2020 ... ... provider of test automation solutions and technical services exclusively to the healthcare industry, ... firm to establish a comprehensive test automation program for its Epic EHR. SIH ...
Breaking Medicine Technology:
Cached News: